Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Coliseum Capital’s 13D On LHC Group, Inc. (LHCG) & Cross-Trade Transactions

Following 13D filings from the SEC is important, and not only when it comes to changes in notable investors’ equity portfolios per se, but also when hedge funds disclose other moves that caused them issue the filing. Coliseum Capital, an activist hedge fund managed by Christopher Shackelton and Adam Gray, recently filed an amendment to its 13D filing which discloses their ownership of 2.6 million shares of LHC Group, Inc. (NASDAQ:LHCG), with the value of the stake amounting to $57.4 million (at current prices)


Even though the amendment did not involve any changes in the number of shares held, it disclosed some information that might be useful for retail investors. The filing disclosed the list of entities that hold the LHC Group, Inc. (NASDAQ:LHCG) stock, and you can see them below:

Explanatory Note: This Amendment No. 2 (this “Amendment”), to the Schedule 13D (the “Initial 13D”) filed by the Filers (as defined below in Item 2) with the U.S. Securities and Exchange Commission (the “Commission”) on November 16, 2012, as amended and supplemented by Amendment No. 1 to the Initial 13D filed on March 14, 2013, amends and supplements the items set forth herein. As used in this statement, the term “Filers” collectively refers to:

• Coliseum Capital Management, LLC, a Delaware limited liability company (“CCM”);

• Coliseum Capital, LLC, a Delaware limited liability company (“CC”);

• Coliseum Capital Partners, L.P., a Delaware limited partnership (“CCP”);

• Coliseum Capital Partners II, L.P., a Delaware limited partnership (“CCP2”);

• Blackwell Partners, LLC, a Georgia limited liability company (“Blackwell”);

• Adam Gray (“Gray”); and

• Christopher Shackelton (“Shackelton”).

Also, the filing mentioned cross-trade transactions, not included in the open market: “On September 16, 2013, CCP2 acquired 127,678 shares of Stock from CCP and 59,609 shares of Stock from Blackwell.”

Aside from Coliseum, we should mention some other hedge funds that have been bullish on LHC Group, Inc. (NASDAQ:LHCG) in the latest round of 13F filings, including Aqr Capital Management, managed by Cliff Asness, Steven Cohen’s Sac Capital Advisors, and Joel Greenblatt’s Gotham Asset Management.

Recommended Reading:

Activist Jana Partners Buys a Boatload of Safeway Inc. (SWY)

Billionaire Carl Icahn Unloads Some WebMD Health Corp. (WBMD) Shares

Mario Gabelli On Tesla Motors Inc (TSLA) & Elon Musk: ‘I Am Not So Sure He Should Be Selling Direct’

Disclosure: none

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.